Fibromyalgia Severity: Role of Resilience and Family Dynamics
Key facts
- Who runs it
- Antalya Training and Research Hospital
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 194 people enrolled
- Started
- 28 Nov 2024
- Ended
- 1 Mar 2025
- Type of study
- Observational, 2 groups
- Record updated
- 30 April 2025
Who can take part
- Age
- 25 years to 45 years
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Age range: Women between the ages of 25-45
- Diagnosis: For fibromyalgia Group: Individuals diagnosed according to the 2016 revision of the American College of Rheumatology's 2010/2011 fibromyalgia diagnostic criteria. For healthy Control Group: Healthy women without a fibromyalgia diagnosis
- Consent: Individuals who volunteered to participate in the research processes and gave informed consent regarding the details of participation and signed the consent form
Who cannot take part
- Serious medical conditions: Individuals with serious health problems such as autoimmune diseases, cancer, severe heart and lung diseases, or acute pain caused by trauma, surgery, inflammatory joint diseases, etc
- Psychiatric conditions: Individuals with psychiatric diseases, medication use, or whose mental state may affect their ability to understand and complete the survey questions
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This cross-sectional survey study aims to examine the resilience and family dynamics between newly diagnosed fibromyalgia (FM) patients and healthy individuals. The study will analyze demographic data including parental attitude and childhood trauma and resilience levels using the Connor-Davidson Resilience Scale (CD-RISC-10) in fibromyalgia patients and healthy controls. The Revised Fibromyalgia Impact Questionnaire (FIQR) will also be administered to FM patients to determine the total impact and severity of the disease (mild, moderate, severe, very severe). In addition to aiming to reveal how FM patients compare to healthy individuals in terms of resilience and parental attitude, this study will also examine the relationship between disease severity and these psychosocial variables. As a result, the data obtained are expected to reveal both potential differences in resilience and family problems in FM patients and the relationship of these factors with disease severity.
The 2 groups in the trial
- Fibromyalgia group
Individuals diagnosed with fibromyalgia according to the 2016 ACR criteria. Participants will be recruited from the Physical Medicine and Rehabilitation Clinic at Antalya City Hospital. Inclusion Criteria: Female, aged 25-45 years Diagnosis of fibromyalgia according to the 2016 revision of 2010/2011 ACR criteria Able to provide informed consent
- Healthy control group
Age- and sex-matched healthy female individuals. No diagnosis of fibromyalgia or any other chronic pain condition. Recruited from the community or other appropriate sources. Inclusion Criteria: * Female, aged 25-45 years * No history of fibromyalgia or other chronic pain conditions * Able to provide informed consent
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Impact of Resilience and Family Dynamics on Disease Severity in Women With Fibromyalgia: Comparison With Healthy Controls
- Record updated
- 30 April 2025